MedPath

Comparison of dexmedetomidine and alfentanil before brain shock on patient's agitatio

Phase 2
Conditions
Agitation.
Restlessness and agitation
Registration Number
IRCT2014103119769N1
Lead Sponsor
Arak University of Medical Sciences, Vice Chancellor for Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
75
Inclusion Criteria

1.ASA class I–II
2.Age between 18-50 years old
3.Patients satisfaction
4.Not pregnant
5.No history of cardiovascular diseases (Arrhythmia, ischemia, and heart block)
6.Not taking beta-receptor blockers
7.Not taking opioids

Exclusion criteria:
1.Lack of patients cooperation
2.Patients who have tonic-clonic seizures less than 25 seconds.
3.Patients who need more than 60% of energy for tonic-clonic seizure.
4.Severe hemodynamic instability requiring medical treatment.
5.sensitivity to the drugs used in this study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath